
Top JPMorgan investment banker brings his talents — and connections — to the biotech startup crew on board Flagship
Stephen Berenson had a 33-year run at JPMorgan before he stepped out as vice chairman of investment banking at the beginning of the year. By his own account, the 57-year-old had taken any number of companies public, worked any number of M&A deals.
But he wanted to do “something completely new and completely transformative.”
So today you can welcome him to the biotech world.
Berenson is Noubar Afeyan’s latest top recruit at Flagship Pioneering, the startup venture group that likes to launch 7 or 8 or 9 new platform companies a year, all of which are looking to do something new and completely transformative in biotech.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.